Previous 10 | Next 10 |
Since my last article in July, Antares has rallied over 20%, finally getting back to the lower end of where it was trading pre-COVID-19. This rally presumably has to do with the company returning to solid growth in Q2 and reporting a quarterly profit. Additionally, management made...
Analysts Have High Hopes For These Penny Stocks When it comes to penny stocks , they’re a dime a dozen. There are thousands of stocks under $5 to choose from. The biggest thing traders focus on is how to make money with penny stocks quickly . That’s one of the ...
Antares Pharma (ATRS) has entered into an exclusive license agreement with Ferring Pharmaceuticals for the marketed product NOCDURNA (desmopressin acetate), which is indicated for the treatment of nocturia due to nocturnal polyuria in adults who awaken at least two times per night to uri...
EWING, N.J., Oct. 01, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today announced that it entered into an exclusive license agreement with Ferring Pharmaceuticals (“Ferring”), a research-drive...
EWING, N.J., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief Executive Officer, is scheduled to present at the H.C. Wainwright 22 nd Annual G...
EWING, N.J., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today announced the appointment of Tram Bui as Vice President of Corporate Communications and Investor Relations. Ms. Bui will succeed...
Image source: The Motley Fool. Antares Pharma Inc (NASDAQ: ATRS) Q2 2020 Earnings Call Aug 6, 2020 , 8:30 a.m. ET Operator Continue reading
The following slide deck was published by Antares Pharma, Inc. in conjunction with their 2020 Q2 earnings Read more ...
Start Time: 08:30 End Time: 09:16 Antares Pharma, Inc. (ATRS) Q2 2020 Earnings Conference Call August 06, 2020, 08:30 AM ET Company Participants Robert Apple - President and CEO Fred Powell - EVP and CFO John Howarth - VP, Corporate Affairs Conference Call Participants ...
Antares Pharma (NASDAQ: ATRS ) : Q2 GAAP EPS of $0.01 beats by $0.01 . More news on: Antares Pharma, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Hart-Scott-Rodino Waiting Period Expires for Halozyme's Acquisition of Antares Pharma PR Newswire SAN DIEGO , May 12, 2022 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) (" Halozyme ") today announced that the waiting period unde...
Antares Pharma Inc shares ( NASDAQ: ATRS ) are up 45% on Wednesday after Halozyme Therapeutics said it will buy the New Jersey-headquartered company for $960 million in cash. Details of the agreement The deal translates to $5.60 per share for Antares Pharma shareholders that...